NT-proBNP在心血管系统疾病中的应用进展  

Application of N-terminal pro-B-type natriuretic peptide in cardiovascular diseases

作　　者：罗威[1] 张原琪(审校)[1] Luo Wei;Zhang Yuanqi(Department of Laboratory Medicine,Second People's Hospital of Yulin,Yulin 537000,China)

机构地区：[1]玉林市第二人民医院检验科,玉林537000

出　　处：《国际医药卫生导报》2022年第7期942-946,共5页International Medicine and Health Guidance News

基　　金：玉林市科学研究与技术开发计划(20170803)。

摘　　要：氨基末端B型钠尿肽原(NT-proBNP)在心血管系统疾病中的应用受到了广泛的关注,尤其是在心力衰竭、冠心病、高血压、糖尿病等疾病的诊断、危险分级及预后评估等方面均取得了显著成效。本文对以上几个方面的研究进展作一综述。The application of N-terminal pro-B-type natriuretic peptide(NT-proBNP)in cardiovascular diseases has been widely noticed,especially in the diagnosis,risk classification,and prognosis evaluation of heart failure,coronary heart disease,hypertension,diabetes,and other diseases,and remarkable achievements have been made.In this paper,the research progress in the above aspects is reviewed.

关 键 词：NT-PROBNP 心血管系统 心力衰竭 

分 类 号：R54[医药卫生—心血管疾病]